Irisin expression was significantly reduced in patients with non-alcoholic steatohepatitis (NASH) and in murine models of liver injury induced by ischemia-reperfusion (I/R) [32]. Here, FNDC5 is linked to metabolic dysfunction-associated steatohepatitis.